The Biotech industry is up 3.4% in the last week, with Innovent Biologics up 9.0%. This means that the industry has gained 14% over the past year. As for the next few years, earnings are expected to grow by 46% per annum.
Has the Hong Kong Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sun, 29 Jan 2023 | HK$467.1b | HK$34.9b | -HK$35,242,741,407.00 | 31.3x | -13.3x | 13.4x |
Tue, 27 Dec 2022 | HK$388.0b | HK$33.7b | -HK$33,948,658,471.00 | 23.1x | -11.4x | 11.5x |
Thu, 24 Nov 2022 | HK$352.3b | HK$33.1b | -HK$33,281,981,877.00 | 21.2x | -10.6x | 10.7x |
Sat, 22 Oct 2022 | HK$324.5b | HK$33.7b | -HK$32,118,113,104.00 | 16.6x | -10.1x | 9.6x |
Mon, 19 Sep 2022 | HK$315.6b | HK$34.2b | -HK$33,501,064,041.00 | 20.7x | -9.4x | 9.2x |
Wed, 17 Aug 2022 | HK$335.0b | HK$32.8b | -HK$46,025,407,450.00 | 12.1x | -7.3x | 10.2x |
Fri, 15 Jul 2022 | HK$365.0b | HK$33.0b | -HK$46,533,006,363.00 | 14x | -7.8x | 11.1x |
Sun, 12 Jun 2022 | HK$357.2b | HK$33.0b | -HK$46,592,039,317.00 | 14.7x | -7.7x | 10.8x |
Tue, 10 May 2022 | HK$314.0b | HK$34.2b | -HK$45,397,203,424.00 | 12.8x | -6.9x | 9.2x |
Thu, 07 Apr 2022 | HK$372.3b | HK$36.4b | -HK$46,242,884,784.00 | 14.7x | -8.1x | 10.2x |
Sat, 05 Mar 2022 | HK$326.8b | HK$34.0b | -HK$31,239,577,575.00 | 13.7x | -10.5x | 9.6x |
Mon, 31 Jan 2022 | HK$293.1b | HK$31.1b | -HK$31,841,442,755.00 | 11.3x | -9.2x | 9.4x |
Wed, 29 Dec 2021 | HK$379.2b | HK$31.1b | -HK$31,826,765,471.00 | 13.2x | -11.9x | 12.2x |
Fri, 26 Nov 2021 | HK$516.9b | HK$31.0b | -HK$31,721,285,866.00 | 13.7x | -16.3x | 16.7x |
Sun, 24 Oct 2021 | HK$492.3b | HK$30.7b | -HK$31,774,543,189.00 | 15.3x | -15.5x | 16x |
Tue, 21 Sep 2021 | HK$521.3b | HK$30.4b | -HK$31,436,180,691.00 | 16.5x | -16.6x | 17.1x |
Thu, 19 Aug 2021 | HK$514.0b | HK$30.2b | -HK$32,058,827,347.35 | 15.1x | -16x | 17x |
Thu, 03 Jun 2021 | HK$629.6b | HK$27.8b | -HK$26,637,487,691.09 | 21.6x | -23.6x | 22.7x |
Sun, 07 Mar 2021 | HK$546.6b | HK$24.0b | -HK$26,645,675,939.75 | 66.8x | -20.5x | 22.7x |
Wed, 09 Dec 2020 | HK$351.8b | HK$20.1b | -HK$13,901,301,810.97 | 43.2x | -25.3x | 17.5x |
Tue, 01 Sep 2020 | HK$337.6b | HK$17.2b | -HK$11,180,934,453.59 | 52x | -30.2x | 19.7x |
Fri, 05 Jun 2020 | HK$249.8b | HK$16.9b | -HK$10,409,928,242.87 | 30.4x | -24x | 14.7x |
Mon, 09 Mar 2020 | HK$184.8b | HK$17.1b | -HK$7,752,252,997.18 | 35.8x | -23.8x | 10.8x |
-22.8x
Which industries have driven the changes within the Hong Kong Healthcare industry?
HK Market | 2.72% | |
Healthcare | 1.88% | |
Biotech | 3.43% | |
Biotech | 3.43% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
1801 Innovent Biologics | HK$47.00 | 9.0% +HK$6.0b | 52.8% | PS13.7x | |
9926 Akeso | HK$51.00 | 6.7% +HK$2.7b | 151.9% | PS142.9x | |
9995 RemeGen | HK$68.90 | 4.3% +HK$1.5b | 43.2% | PE116.5x | |
1952 Everest Medicines | HK$27.60 | 18.5% +HK$1.3b | 8.9% | PS6735.5x | |
2162 Keymed Biosciences | HK$69.90 | 5.9% +HK$1.1b | 177.4% | PS80.6x |